Xencor reported $15.75M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Amgen AMGN:US $ 1256M 147M
Arrowhead Research ARWR:US $ 5.89M 4.71M
Biogen BIIB:US $ 434.8M 36.1M
Bristol Myers Squibb BMY:US $ 2882M 62M
Cytokinetics CYTK:US $ 14.08M 5.76M
Epizyme EPZM:US $ 5M 2.91M
Karyopharm Therapeutics KPTI:US $ 1.69M 1.75M
Macrogenics MGNX:US $ 2.61M 1.12M
Novartis NOVN:VX 4.97B 114M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Seattle Genetics SGEN:US $ 128.87M 41.64M
Xencor XNCR:US $ 15.75M 3.84M